Abstracts Archive - Page 153 of 1683 - ATC Abstracts

2022 American Transplant Congress
Preferred Language And Disease Severity Predict Evaluation For Liver Transplantation Among Patients Admitted With Alcoholic Hepatitis
D. J. Cloonan¹, J. Broekhuis², T. Coe¹, S. Criss³, S. Li³, E. Bethea¹, H. Yeh¹, L. Dageforde¹
¹Massachusetts General Hospital/Harvard Medical School, Boston, MA, ²Beth Israel Deaconess Medical Center/Harvard Medical School, Boston, MA, ³Harvard Medical School, Boston, MA
*Purpose: Liver transplantation (LT) for alcoholic hepatitis (AH) without a sobriety period is a relatively new practice. While AH patients are no longer categorically excluded…
2022 American Transplant Congress
National Survey of Solid Organ Transplant Pharmacist Training and Early Career Research Success
A. Lichvar¹, M. Chandran², M. Durst³, S. Fredrick⁴, D. Pierce⁵, H. Sweiss⁶, A. Szczepanik⁷, J. Melaragno⁸
¹UC San Diego Health, La Jolla, CA, ²Pharmacy, UNC Hospitals, Chapel Hill, NC, ³Aurora St. Luke's Medical Center, Waukesha, WI, ⁴University of Rochester Medical Center, Buffalo, NY, ⁵University of Illinois at Chicago, Chicago, IL, ⁶University Health - University Hospital, San Antonio, TX, ⁷University of Maryland, Baltimore, MD, ⁸University of Rochester, Rochester, NY
*Purpose: The purpose of this study is to assess the incidence of early career publications of solid organ transplant (SOT) clinical pharmacists and to describe…
2022 American Transplant Congress
Significance of C4d Expression in Peritubular Capillary Concurrent with Microvascular Inflammation in For-Cause Biopsies of ABO-Incompatible Renal Allografts
H. Cho¹, C. Baek², H. Kim³
¹Department of Pathology, Asan Medical Center, Seoul, Korea, Republic of, ²Department of Internal Medicine, Asan Medical Center, Seoul, Korea, Republic of, ³Asan Medical Center, Seoul, Korea, Republic of
*Purpose: ABO incompatible (ABOi) kidney transplantation (KT) has been increasing due to severe organ shortages. Pathologic diagnosis of antibody-mediated rejection (ABMR) in ABOi patients is…
2022 American Transplant Congress
Association of Kidney Transplant Recipients’ Knowledge of Cardiovascular Disease with Adoption of Cardiovascular Disease Risk Reduction Activities
M. Fallahzadeh¹, E. Ku², D. Adey², D. Tuot²
¹UCSF, Nashville, TN, ²UCSF, San Francisco, CA
*Purpose: Patient understanding of disease is one key component to engagement in health and participation in risk reduction activities. We examined the association between kidney…
2022 American Transplant Congress
The Impact of New-Onset Diabetes After Transplantation on Survival and Major Cardiovascular Events in Korean Kidney Transplantation Recipients
E. Kang¹, J. Lee², D. Kang³, Y. Jang⁴, S. Park⁵, Y. Kim⁴, D. Kim⁴, K. Joo⁴, Y. Kim⁴, M. Park⁶, Y. Lim⁷, H. Lee⁴
¹Ewha Womans University Seoul Hospital, Seoul, Korea, Republic of, ²Dongguk University Ilsan Hospital, Goyang, Korea, Republic of, ³Chung-Ang University, Seoul, Korea, Republic of, ⁴Seoul National University Hospital, Seoul, Korea, Republic of, ⁵Seoul National University College of Medicine, Seoul, Korea, Republic of, ⁶Informations and Statistics, Chungnam National University, Daejeon, Korea, Republic of, ⁷Applied Statistics, Chung-Ang University, Seoul, Korea, Republic of
*Purpose: New-onset diabetes after transplantation (NODAT) is a frequent complication in kidney transplant (KT) recipients with unfavorable outcomes, although a nationwide study on epidemiology and…
2022 American Transplant Congress
Broad Panel Genetic Testing for Chronic Kidney Disease in the Transplant Center
A. Bhalla¹, D. Raible², V. Balaraman¹, M. Talwar¹
¹James D. Eason Transplant Institute, Methodist University Hospital, Memphis, TN, ²Natera, Inc., Austin, TX
*Purpose: Genetic testing is an emerging tool for ‌the evaluation of patients with end-stage renal disease (ESRD). In kidney transplantation (KT), testing can identify disease…
2022 American Transplant Congress
Gm2a: A Novel Regulatory Pathway Controlling CD8⁺ T Cell Alloimmunity
K. M. Baecher¹, J. Bazzano¹, K. Tong¹, M. Fribourg², P. Cravedi², P. S. Heeger², M. L. Ford¹
¹Department of Surgery, Emory University, Atlanta, GA, ²Mount Sinai School of Medicine, New York, NY
*Purpose: Transplant recipients experience lifelong immunosuppression, yet studies have shown that a subset of patients may be able to retain stable graft function even with…
2022 American Transplant Congress
High Incidence Of Anti-HLA DSA And Late Allograft Dysfunction In Solid Organ Transplant Recipients Hospitalized With Covid-19
J. T. Killian, S. Roman Soto, V. Hauptfeld-Dolejsek, E. B. Levitan, P. M. Porrett, V. Kumar, F. E. Lund, J. A. Houp
University of Alabama at Birmingham, Birmingham, AL
*Purpose: Solid organ transplant (SOT) recipients admitted for COVID-19 commonly experience immunosuppression reduction and acute allograft dysfunction. Given the number of SOT patients hospitalized for…
2022 American Transplant Congress
Unravelling the Stage-Shift of Acute Rejection by Urine QSant
W. Yazar¹, N. Titzler¹, R. Sarwal¹, M. Sarwal², S. Ghosh¹
¹Nephrosant, Brisbane, CA, ²NephroSant, Brisbane, CA
*Purpose: Suboptimal performance in current methods for allograft monitoring underscores the unmet need for enhanced immunosurveillance accuracy, to uncover the alloimmunity flux. QSant[Yang et al,…
2022 American Transplant Congress
National Attitudes Towards Early Liver Transplantation for Alcoholic Liver Disease
J. Mitchell¹, K. Nijhar¹, K. Herrick-Reynolds², H. Sung¹, P. Chen¹, D. L. Segev¹, E. King¹, A. Cameron¹
¹Department Of Surgery, Johns Hopkins University, Baltimore, MD, ²Department Of Surgery, Walter Reed National Military Medical Center, Bethesda, MD
*Purpose: Pre-transplant abstinence requirements, notably the 6-month sobriety guideline, limit access to liver transplant for patients with severe alcoholic hepatitis (SAH). This study examines the…